 |
 |
|
|
|
||||||||||
|
||||||||||
|
|
|||||||||
|
||||||||||
Uncontainable drug costs have spurred employers to take a fresh look at how their pharmacy benefit managers might be hiding revenue.
David M. Katz, CFO.com | US
October 28, 2005
As a practicing physician, I find pharmacy benefit corporations to be the weakest link in the chain of quality of care and patient safety. For example, Google the three words, complaints, Merck, and Medco (together), and you will get over 25,000 hits. Every week I struggle dealing with the exingencies caused by their actions.
Posted by Douglas Marsh | February 16, 2006 03:41 pm
© CFO Publishing Corporation 2009. All rights reserved.